Literature DB >> 11384694

Relative glucose tolerance and subsequent development of hypertension in pregnancy.

K E Innes1, J H Wimsatt, R McDuffie.   

Abstract

OBJECTIVE: To test the hypothesis that relative carbohydrate tolerance, an indicator of insulin resistance, predicts subsequent risk for hypertension of pregnancy among previously normoglycemic, normotensive women.
METHODS: We conducted a nested case-control study in women enrolled at a large Colorado urban health maintenance organization. Subjects were previously healthy pregnant women who tested abnormal on their initial 50-g glucose screens and subsequently completed 3-hour, 100-g oral glucose tolerance tests. Cases were 54 previously normotensive women who subsequently developed hypertension and controls were 51 subjects with normotensive pregnancies, matched to cases on parity. Subjects diagnosed with gestational diabetes (17 cases, six controls) were excluded from the main analyses.
RESULTS: Among the 82 normoglycemic women (45 controls, 37 cases, 13 preeclampsia, 24 gestational hypertension), mean post-load glucose levels and total glucose area under the curve were significantly higher in cases than in controls (P < or =.04) and were positively correlated with peak mean arterial pressure. After adjustment for potential confounders, 2-hour post-load glucose levels remained strongly related to risk for hypertension (adjusted odds ratios = 1.48; 95% confidence interval 1.13, 1.92, per 10 mg/dL increase) and to peak mean arterial blood pressure (r =.23, P =.04), as did total glucose area under the curve (P < or =.04). Cases were also more likely to have had one abnormal glucose tolerance test (28% versus 5%, P =.004). Stratifying analyses by case severity (preeclampsia and gestational hypertension) yielded similar results. Among all subjects, more cases than controls were also diagnosed with gestational diabetes (31% versus 12%, P =.008).
CONCLUSION: These findings are consistent with the hypothesis that insulin resistance precedes the clinical onset of hypertension in pregnancy, and may be important in the etiology of hypertension.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11384694     DOI: 10.1016/s0029-7844(01)01342-4

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  17 in total

Review 1.  Animal models of preeclampsia.

Authors:  Eduardo Podjarny; Gyorgy Losonczy; Chris Baylis
Journal:  Semin Nephrol       Date:  2004-11       Impact factor: 5.299

Review 2.  Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia.

Authors:  Babbette D LaMarca; Jeffery Gilbert; Joey P Granger
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

3.  Maternal hyperglycemia and adverse pregnancy outcomes in Dar es Salaam, Tanzania.

Authors:  Anne Marie Darling; Enju Liu; Said Aboud; Willy Urassa; Donna Spiegelman; Wafaie Fawzi
Journal:  Int J Gynaecol Obstet       Date:  2014-01-02       Impact factor: 3.561

Review 4.  Pre-eclampsia and long-term maternal health.

Authors:  David Williams
Journal:  Obstet Med       Date:  2012-08-20

5.  Late pregnancy complications in polycystic ovarian syndrome.

Authors:  I Katsikis; M Kita; A Karkanaki; N Prapas; D Panidis
Journal:  Hippokratia       Date:  2006-07       Impact factor: 0.471

6.  Retinol binding protein 4--a novel association with early-onset preeclampsia.

Authors:  Edi Vaisbuch; Roberto Romero; Shali Mazaki-Tovi; Offer Erez; Sun Kwon Kim; Tinnakorn Chaiworapongsa; Francesca Gotsch; Nandor Gabor Than; Zhong Dong; Percy Pacora; Ronald Lamont; Lami Yeo; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Perinat Med       Date:  2010-03       Impact factor: 1.901

7.  Maternal serum adiponectin multimers in gestational diabetes.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Edi Vaisbuch; Offer Erez; Pooja Mittal; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Percy Pacora; Lami Yeo; Francesca Gotsch; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

8.  Cardiovascular risk in women after metabolic complications in pregnancy.

Authors:  A H E M Maas; A W J van 't Hof; M J de Boer
Journal:  Neth Heart J       Date:  2007-12       Impact factor: 2.380

9.  Maternal serum adiponectin multimers in preeclampsia.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Edi Vaisbuch; Juan Pedro Kusanovic; Offer Erez; Francesca Gotsch; Tinnakorn Chaiworapongsa; Nandor Gabor Than; Sun Kwon Kim; Chia-Ling Nhan-Chang; Cristiano Jodicke; Percy Pacora; Lami Yeo; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Pooja Mittal
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

Review 10.  Placental ischemia and cardiovascular dysfunction in preeclampsia and beyond: making the connections.

Authors:  Jeffrey S Gilbert; Mark J Nijland; Penny Knoblich
Journal:  Expert Rev Cardiovasc Ther       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.